Allegion Stock Price, News & Analysis (NYSE:ALLE)

Allegion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALLE."

Allegion announced a quarterly dividend on Thursday, September 5th. Investors of record on Monday, September 16th will be paid a dividend of $0.27 per share on Monday, September 30th. This represents a $1.08 annualized dividend and a dividend yield of 1.06%. The ex-dividend date is Friday, September 13th. View Allegion's Dividend History.

Allegion PLC (NYSE:ALLE) announced its earnings results on Thursday, July, 25th. The scientific and technical instruments company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.31 by $0.05. The scientific and technical instruments company earned $731.20 million during the quarter, compared to analysts' expectations of $750.76 million. Allegion had a return on equity of 68.47% and a net margin of 15.65%. The firm's revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period last year, the business posted $1.19 earnings per share. View Allegion's Earnings History.

Allegion is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Allegion.

Allegion will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Allegion updated its FY19 earnings guidance on Thursday, July, 25th. The company provided EPS guidance of $4.80-4.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.86. The company issued revenue guidance of +4.5-5.5% yr/yr to ~$2.85-2.89 billion, compared to the consensus revenue estimate of $2.89 billion.

7 brokers have issued 1 year target prices for Allegion's shares. Their forecasts range from $92.00 to $116.00. On average, they anticipate Allegion's stock price to reach $107.71 in the next twelve months. This suggests a possible upside of 5.8% from the stock's current price. View Analyst Price Targets for Allegion.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allegion in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allegion.

Headlines about ALLE stock have trended very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Allegion earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave news coverage about the scientific and technical instruments company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Allegion.

Allegion saw a drop in short interest during the month of September. As of September 15th, there was short interest totalling 4,690,000 shares, a drop of 6.0% from the August 15th total of 4,990,000 shares. Based on an average daily trading volume, of 674,600 shares, the days-to-cover ratio is presently 7.0 days. Currently, 5.1% of the shares of the company are short sold. View Allegion's Current Options Chain.

Some companies that are related to Allegion include ATLAS COPCO AB/S (ATLKY), Roper Technologies (ROP), FANUC LTD JAPAN/ADR (FANUY), MURATA MFG CO L/ADR (MRAAY), Eaton (ETN), Johnson Controls International (JCI), Mitsui & Co Ltd (MITSY), Ingersoll-Rand (IR), Cintas (CTAS), ASSA ABLOY AB/S (ASAZY), Ball (BLL), Parker-Hannifin (PH), Stanley Black & Decker (SWK), Komatsu (KMTUY) and SANDVIK AB/ADR (SDVKY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allegion investors own include General Electric (GE), AbbVie (ABBV), Citigroup (C), Walmart (WMT), NVIDIA (NVDA), Abbott Laboratories (ABT), Nucor (NUE), Pfizer (PFE), UnitedHealth Group (UNH) and FLIR Systems (FLIR).

Allegion's stock is owned by a number of of retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.02%), Gateway Investment Advisers LLC (0.02%), Murphy Capital Management Inc. (0.01%), Crossmark Global Holdings Inc. (0.01%), Wealthfront Advisers LLC (0.01%) and Financial Gravity Wealth Inc. (0.00%). Company insiders that own Allegion stock include Chris E Muhlenkamp, Douglas P Ranck, Jeffrey M Wood, Jeffrey N Braun, Patrick S Shannon, Timothy P Eckersley and Tracy L Kemp. View Institutional Ownership Trends for Allegion.

ALLE stock was sold by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, State of Alaska Department of Revenue, Financial Gravity Wealth Inc., Crossmark Global Holdings Inc. and Murphy Capital Management Inc.. Company insiders that have sold Allegion company stock in the last year include Chris E Muhlenkamp, Douglas P Ranck, Jeffrey M Wood, Jeffrey N Braun, Patrick S Shannon, Timothy P Eckersley and Tracy L Kemp. View Insider Buying and Selling for Allegion.

ALLE stock was bought by a variety of institutional investors in the last quarter, including Wealthfront Advisers LLC. View Insider Buying and Selling for Allegion.

Shares of ALLE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALLE stock can currently be purchased for approximately $101.79.

Allegion has a market capitalization of $9.51 billion and generates $2.73 billion in revenue each year. The scientific and technical instruments company earns $434.90 million in net income (profit) each year or $4.50 on an earnings per share basis. Allegion employs 11,000 workers across the globe.View Additional Information About Allegion.

The official website for Allegion is http://www.allegion.com/.

Allegion's mailing address is BLOCK D IVEAGH COURT HARCOURT ROAD, DUBLIN L2, 46032. The scientific and technical instruments company can be reached via phone at 353-1254-6200 or via email at [email protected]